Vir Biotechnology Inc

Small-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.90

+0.24 (+2.77%)

As of Aug 8, 1:44 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target +90.8% upside

Low Target $13.41

Average Target $16.98

High Target $22.24

Current Price $8.90

Current
$8.90

Target
$16.98

$13.41 $16.98 avg $22.24

Scenario Analysis

Bear Case

$13.41

50.7%

Low target

Base Case

$16.98

+90.8%

Avg target

Bull Case

$22.24

+149.9%

High target

Risk/Reward

3.0x

Favorable

Price in Context

52-Week High

$11.66

-23.7% from high

52-Week Low

$4.16

+114.2% from low

Target vs 52W High

$16.98

+45.6% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	79%	$257.58	+4.7%
AMGN Amgen Inc	Hold	43	49%	$190.87	-53.6%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+172.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.6%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-90.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-55.6%
RVMD Revolution Medicines Inc	Strong Buy	29	93%	$114.11	-44.4%
BIIB Biogen Inc	Buy	44	64%	$91.45	-56.0%